Please login to the form below

Not currently logged in
Email:
Password:

Firmagon

This page shows the latest Firmagon news and features for those working in and with pharma, biotech and healthcare.

NICE finally set to back wider use of Ferring's Firmagon

NICE finally set to back wider use of Ferring's Firmagon

Ferring's Firmagon (degarelix) has been recommended for use by the NHS in England by the country's cost-effectiveness watchdog NICE. ... This has been a long process but throughout … we have maintained our firm belief that Firmagon can have a

Latest news

  • NICE gives partial backing to Ferring's prostate cancer drug NICE gives partial backing to Ferring's prostate cancer drug

    said. "Patients with pre-existing CVD are most at risk and the evidence shows that Firmagon has a higher chance of reducing that.". ... Ferring estimates that Firmagon costs around £12, 300 ($20, 650) per course - including administration - which NICE

  • Close but no cigar

    Acne vulgaris. US, Europe. Degarelix. FIRMAGON (Ferring). Prostate cancer. US. Lanthanum carbonate.

More from news
Approximately 2 fully matching, plus 1 partially matching documents found.

COVID-19 Updates and Daily News

Featured jobs

PMHub

Add my company
Aptus Health

Aptus Health is dedicated to advancing health engagement. The company offers end-to-end digital health engagement solutions spanning all areas of...

Latest intelligence

AI and genomics: a revolution in drug discovery and development
...
Working together against COVID-19
Analysing social media conversations to see what HCPs are saying online about the global pandemic...
Vicky Bramham, Managing Director at OPEN Health PR shares tips on media relations during COVID-19
Vicky speaks with freelance health journalist Jacqui Thornton who gives her expert view on how best to approach media relations during this unprecedented time....

Infographics